We are live on ! Find out more
BCM

Brookmont Capital Management Portfolio holdings

AUM $186M
1-Year Est. Return 10.11%
This Fund
S&P 500
This Quarter Est. Return
+4.65%
1 Year Est. Return
+10.11%
3 Year Est. Return
+36.63%
5 Year Est. Return
+48.26%
10 Year Est. Return
+211.29%
AUM
$270M
AUM Growth
+$16.6M
Cap. Flow
+$5.68M
Cap. Flow %
2.1%
Top 10 Hldgs %
45.2%
Holding
54
New
4
Increased
12
Reduced
36
Closed
–

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$2.68M
2
AMGN icon
Amgen
AMGN
+$2.39M
3
PKG icon
Packaging Corp of America
PKG
+$1.97M
4
HUBB icon
Hubbell
HUBB
+$1.64M
5
MSFT icon
Microsoft
MSFT
+$510K

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$730K
2
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$502K
3
PG icon
Procter & Gamble
PG
+$419K
4
MCHP icon
Microchip Technology
MCHP
+$370K
5
HON icon
Honeywell
HON
+$292K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.52%
2 Healthcare 13.85%
3 Financials 13.75%
4 Energy 12.85%
5 Technology 11.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HD icon
1
Home Depot
HD
$332B
$31.3M 11.57%
213,134
-740
-0.3% -$105K
MCHP icon
2
Microchip Technology
MCHP
$40.7B
$12.2M 4.5%
329,902
-10,488
-3% -$370K
JPM icon
3
JPMorgan Chase
JPM
$933B
$12.2M 4.49%
138,363
-3,276
-2% -$289K
UN
4
DELISTED
Unilever NV New York Registry Shares
UN
$9.7M 3.59%
195,148
+25
+0% +$1.12K
MCD icon
5
McDonald's
MCD
$191B
$9.64M 3.56%
74,360
-897
-1% -$113K
WFC icon
6
Wells Fargo
WFC
$258B
$9.63M 3.56%
173,101
-145
-0.1% -$8.23K
CVX icon
7
Chevron
CVX
$383B
$9.63M 3.56%
89,716
-1,312
-1% -$147K
JNJ icon
8
Johnson & Johnson
JNJ
$617B
$9.56M 3.54%
76,774
-54
-0.1% -$6.45K
PAYX icon
9
Paychex
PAYX
$41.4B
$9.25M 3.42%
157,089
+715
+0.5% +$43.5K
PEP icon
10
PepsiCo
PEP
$191B
$9.19M 3.4%
82,148
-251
-0.3% -$26.9K
RDS.B
11
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$9.19M 3.4%
164,552
-1,176
-0.7% -$66.7K
DEO icon
12
Diageo
DEO
$49.5B
$8.85M 3.27%
76,534
-56
-0.1% -$6.28K
UPS icon
13
United Parcel Service
UPS
$89.5B
$8.75M 3.24%
81,562
+250
+0.3% +$27.3K
SLB icon
14
SLB Ltd
SLB
$72.6B
$8.7M 3.22%
111,361
-936
-0.8% -$76.5K
GE icon
15
GE Aerospace
GE
$368B
$8.62M 3.19%
60,360
-72
-0.1% -$10.4K
ABT icon
16
Abbott
ABT
$183B
$8.47M 3.13%
190,655
-16,877
-8% -$730K
ADI icon
17
Analog Devices
ADI
$179B
$8.18M 3.03%
99,869
-2,338
-2% -$184K
NVS icon
18
Novartis
NVS
$301B
$7.98M 2.95%
119,964
-1,451
-1% -$96.7K
AJG icon
19
Arthur J. Gallagher & Co
AJG
$65.9B
$7.31M 2.7%
129,329
-2,802
-2% -$154K
PARA
20
DELISTED
Paramount Global Class B
PARA
$7.15M 2.65%
103,113
-2,973
-3% -$195K
PG icon
21
Procter & Gamble
PG
$335B
$6.49M 2.4%
72,265
-4,730
-6% -$419K
COP icon
22
ConocoPhillips
COP
$145B
$6.45M 2.38%
129,245
+44
+0% +$2.13K
PNC icon
23
PNC Financial Services
PNC
$99.2B
$4.21M 1.56%
35,007
-898
-3% -$110K
KHC icon
24
Kraft Heinz
KHC
$31.3B
$4.21M 1.56%
46,339
-588
-1% -$53K
USB icon
25
US Bancorp
USB
$98B
$3.88M 1.43%
75,237
-887
-1% -$47.3K
1
2 3

Similar funds

SEP
Signature Equity Partners Columbus, Ohio $186M AUM
CC
Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return
BGA
Battery Global Advisors Boston, Massachusetts $186M AUM 15.74% 1-Year Est. Return
OBC
Oakum Bay Capital Westport, Connecticut $187M AUM
LPCM
Lynwood Price Capital Management Austin, Texas $186M AUM 5.63% 1-Year Est. Return
HC
Hurley Capital New York $187M AUM 23.24% 1-Year Est. Return
AC
AMANSA Capital Raffles City Tower, Singapore $187M AUM 38.38% 1-Year Est. Return
WWM
Whalen Wealth Management Las Vegas, Nevada $187M AUM 18.9% 1-Year Est. Return

Brookmont Capital Management's Q1 2017 Portfolio in Review

As of Q1 2017, Brookmont Capital Management held 54 positions worth $270M, up 6.5% from $254M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Brookmont Capital Management's Q1 2017 filing shows 4 new, 12 increased and 36 reduced positions. Its largest new stake was Gilead Sciences: 38,081 shares worth $2.59M. The largest sale was Abbott, an estimated $730K.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Brookmont Capital Management's largest Q1 2017 buy was Gilead Sciences: 38,081 shares worth $2.59M.
  • Brookmont Capital Management added most to Amgen in Q1 2017, an estimated $2.39M increase.
  • Brookmont Capital Management's biggest Q1 2017 reduction was Abbott, cutting an estimated $730K.
  • Brookmont Capital Management's ten largest holdings make up 45% of its $270M portfolio in Q1 2017.
  • Brookmont Capital Management opened 4 new positions and closed 0 in Q1 2017.
  • Brookmont Capital Management's portfolio value rose 6.5% quarter-over-quarter to $270M.

Based on Brookmont Capital Management's 13F filing for Q1 2017, filed 15 May 2017.